Lulu Chu

Lulu Chu is currently the Director Clinical Scientist in Immunology Cell Therapy at AstraZeneca. They previously held positions as Associate Director at Takeda, where they led modeling and data analysis activities, and as an Associate Director in Quantitative Clinical Pharmacology at AstraZeneca. Lulu’s academic background includes a PhD from Johns Hopkins University and a Bachelor’s degree in Biomedical Engineering from the University of Virginia. Early in their career, they participated in workshops and contributed to significant research on cardiac dynamics and cell therapies.